Search Results 161-170 of 16608 for primary sclerosing cholangitis
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers are also making ...
primary sclerosing cholangitis, or PSC.” John Poterucha, M.D.. Transplant Hepatology. Mayo Clinic. “PSC is a disease of the bile ducts. Think about it as a ...
... primary sclerosing cholangitis, fatty liver disease, Wilson's disease, portal hypertension, congenital hepatic fibrosis and Alagille syndrome. Comprehensive ...
... primary sclerosing cholangitis: Impact of donor and recipient factors. Liver Transpl. 2025 Jun 1; 31 (6):781-792 Epub 2024 Oct 28. View PubMed; Wu T, Mousa OY ...
— Regular consumption of coffee is associated with a reduced risk of primary · sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research ...
The purpose of this study is to assess the safety, tolerability and effectiveness of LJN452 for the treatment of patients who have primary biliary cholangitis.
"PSC is disease of the bile ducts," says Dr. John Poterucha, a Mayo Clinic transplant hepatologist. "Think about it as a deciduous tree, where the liver is the ...
... primary sclerosing cholangitis. Hepatology. 2025 Mar 20 [Epub ahead of print] View PubMed; Kelm ZS, Ron ED, Olson MC, Welle CL, Johnson TF, Boyum JH ...
When Bruce Schwartau was diagnosed with primary sclerosing cholangitis, a chronic liver disease, he understood he'd eventually need a liver transplant.
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.